PRISM BioLab Co.,Ltd announced that it has raised ¥1,500 million in a round of funding on January 24, 2024. The transaction included participation from new investors Eli Lilly and Company and santec Holdings Corporation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,870 JPY | +0.41% | -2.40% | +57.35% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
4,870 JPY | +0.41% | -2.40% | 364M | ||
733.5 USD | +1.19% | +0.99% | 661B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.35% | 364M | |
+12.06% | 107B | |
-0.62% | 29.43B | |
+12.05% | 22.21B | |
-16.05% | 17.75B | |
-6.34% | 17.25B | |
+8.74% | 15.28B | |
-4.89% | 12.2B | |
-2.85% | 10.42B | |
-8.86% | 9.04B |
- Stock Market
- Equities
- 6777 Stock
- News santec Holdings Corporation
- PRISM BioLab Co.,Ltd announced that it has received ¥1.5 billion in funding from santec Holdings Corporation, Eli Lilly and Company